CX‑5461 potentiates imatinib‑induced apoptosis in K562 cells by stimulating KIF1B expression. [PDF]
Dai C +6 more
europepmc +1 more source
8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells. [PDF]
Wu PS +5 more
europepmc +1 more source
Circumvention of Topoisomerase II<i>α</i> Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. [PDF]
Wang X +6 more
europepmc +1 more source
Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II<i>β</i> in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. [PDF]
Carvajal-Moreno J +6 more
europepmc +1 more source
Bioinformatics of Differentially Expressed Genes in Phorbol 12-Myristate 13-Acetate-Induced Megakaryocytic Differentiation of K562 Cells by Microarray Analysis. [PDF]
Lee SH, Park NR, Kim JE.
europepmc +1 more source
Dual PI3K/mTOR inhibitor NVP‑BEZ235 decreases the proliferation of doxorubicin‑resistant K562 cells. [PDF]
Li J +7 more
europepmc +1 more source
6,7-Dimethoxycoumarin Influences the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells through Regulating FOXO3/p27 Signal Pathway. [PDF]
Zheng L +5 more
europepmc +1 more source
Identification of potential pathways and microRNA-mRNA networks associated with benzene metabolite hydroquinone-induced hematotoxicity in human leukemia K562 cells. [PDF]
Yu CH +6 more
europepmc +1 more source
The Flavagline Compound 1-(2-(dimethylamino)acetyl)-Rocaglaol Induces Apoptosis in K562 Cells by Regulating the PI3K/Akt/mTOR, JAK2/STAT3, and MAPK Pathways. [PDF]
Yang X +7 more
europepmc +1 more source
Modification of Polyethylene Glycol-Hydroxypropyl Methacrylate Polymeric Micelles Loaded with Curcumin for Cellular Internalization and Cytotoxicity to Wilms Tumor 1-Expressing Myeloblastic Leukemia K562 Cells. [PDF]
Okonogi S +4 more
europepmc +1 more source

